Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1/SREBP1/SCD1 pathway

IntroductionTriple-negative breast cancer (TNBC) is the most malignant type of breast cancer, and its prognosis is still the worst. It is necessary to constantly explore the pathogenesis and effective therapeutic targets of TNBC. Formononetin is an active ingredient with anti-tumor effects that we s...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Dong Xie, Yulang Jiang, Huan Wang, Lingyi Zhu, Shuangqin Huang, Sheng Liu, Weihong Zhang, Tian Li
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2024-09-01
Σειρά:	Frontiers in Pharmacology
Θέματα:	triple-negative breast cancer ferroptosis Formononetin mammalian target of rapamycin complex1 sterol regulatory element-binding protein 1
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1441105/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!